Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Product NDC
- 72162-1237
- 11-digit product format
- 721621237
- Labeler code
- 72162
- Product ID
- 72162-1237_f117d27f-d753-446f-a7f3-a180fe42233f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA211421
- Marketing category
- ANDA
- Marketing start
- 2020-07-09
- Substance
- CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- Active strength
- 5; 2.5 mg/1; mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| MFM6K1XWDK | CHLORDIAZEPOXIDE HYDROCHLORIDE | 438-41-5 | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| 91ZQW5JF1Z | CLIDINIUM BROMIDE | 3485-62-9 | CLIDINIUM BROMIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72162-1237-1 | 72162123701 | 100 CAPSULE in 1 BOTTLE (72162-1237-1) | 100 capsule | 2023-12-05 | No | No | Historical |